In the current trading session, enVVeno Medical Corporation’s (NVNO) stock is trading at the price of $1.16, a fall of -72.32% over last night’s close. So, the stock is trading at a price that is -79.65% less than its 52-week high of $5.70 and -42.80% better than its 52-week low of $2.03. Based on the past 30-day period, the stock price is -76.85% below the high and +5.17% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, NVNO’s SMA-200 is $3.48.
NVNO’s price to book ratio for the most recent quarter was 0.68, resulting in an 0.64 price to cash per share for the period.
How does enVVeno Medical Corporation (NVNO) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 2 brokerage firms that recommend the stock as a Moderate Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 4.00 in simple terms.
enVVeno Medical Corporation (NVNO): Earnings History
If we examine enVVeno Medical Corporation’s recent earnings history, in the last quarter ended on 6/30/2025, it posted adjusted earnings per share of -$0.33, beating the consensus of -$0.28. In other words, it beat the consensus by -$0.05, resulting in a -17.86% surprise. In the 3 months period before the previous quarter which was closed on 6/30/2025, the stock recorded adjusted earnings per share of -$0.33 in contrast with the Outlook of -$0.28. That was a difference of -$0.05 and a surprise of -17.86%.
enVVeno Medical Corporation (NASDAQ: NVNO) Ownership Details
I will give a breakdown of the key shareholders in enVVeno Medical Corporation (NVNO). Recent figures show that the company’s insiders hold 0.84% of shares. A total of 42 institutional investors hold shares in the company, making 27.28% of its stock and 27.52% of its float.
Jun 30, 2025 , it was reported that the Company’s largest institutional holder is Perceptive Advisors Llc holding total of 1.28 shares that make 6.68% of the company’s total number of shares and are currently priced at 1.54 million.
The securities firm Kingdon Capital Management LLC holds 859.26 shares of NVNO, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 4.46% , and the holding percentage of shares is valued at 1.03 million.
An overview of enVVeno Medical Corporation’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests enVVeno Medical Corporation (NVNO) traded 528,334 shares per day, with a moving average of $4.60 and price change of -3.85. With the moving average of $4.43 and a price change of -3.21, about 289,956 shares changed hands on average over the past 50 days. Finally, NVNO’s 100-day average volume is 194,827 shares, alongside a moving average of $3.77 and a price change of -1.61.
